Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 3 Interventional

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

ClinicalTrials.gov ID: NCT00460967

Public ClinicalTrials.gov record NCT00460967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Effectiveness, in a Multi-Center, Randomized, Sham Controlled Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD)Using Rheopheresis

Study identification

NCT ID
NCT00460967
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 3
Lead sponsor
OccuLogix
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

  • Rheopheresis Device

Device

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
Not listed
Completion
Nov 30, 2009
Last update posted
Nov 6, 2007

2007 – 2009

United States locations

U.S. sites
33
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Retinal Consultants of Arizona Phoenix Arizona 85014
Associated Retina Consultants, LTD. Phoenix Arizona 85020
Mayo Clinic Hospital Phoenix Arizona 85054
Mayo Clinic, Department of Ophthalmology Scottsdale Arizona 85259
Southwest Kidney Institute, PLC, 2149 East Warner Rd. Ste. 109 & 110 Tempe Arizona 85284
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Good Samaritan Hospital Los Angeles California 90017
DSI Brandon Florida 33511
Center for Retina and Macular Disease Winter Haven Florida 33880
University of Illinois at Chicago Chicago Illinois 60612-7315
University of Illinois at Chicago Chicago Illinois 60612
University of Chicago Chicago Illinois 60637
Retina Group of Washington Chevy Chase Maryland 20815
Vitreo-Retinal Associates Worcester Massachusetts 01605
University of Massachuesettes Medical Health Center Worcester Massachusetts 01655
Retinovitreous Associates, Ltd. Cherry Hill New Jersey 08002
Ophthalmic Consultants of Long Island Lynbrook New York 11563
New York Blood Center New York New York 10021-6275
Macula Care New York New York 10021
Vitreous Retina Macula Consultants New York New York 10022
Columbia University New York New York 10032
Retina Associates of Cleveland Beachwood Ohio 44122
Cleveland Clinic Foundation, Cole Eye Institute Cleveland Ohio 44195
The Cleveland Clinic Cleveland Ohio 44195
Retina Associates of Cleveland Lakewood Ohio 44107
University of Pennsylvannia Medical Center Philadelphia Pennsylvania 19104
Texas Retina Associates Dallas Texas 75231
UT Southwestern Medical Center Dallas Texas 75390-9073
Memorial Hermann University of Texas Health Science Center Houston Texas 77030
The Methodist Hospital System Houston Texas 77030
Vitreoretinal Consultants Houston Texas 77030
Fairfax Pathology Associates, Ltd. Annadale Virginia 22003
Retina Group of Washington Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00460967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2007 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00460967 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →